While much of the research into the role of α7nAChR in AD has focused on homomeric α7 receptors, recent work provides evidence for the existence of α7β2 heteromeric receptors and implicates these receptors in neuropathological processes. The gene discussed is CHRNA7; the disease is Alzheimer disease.